AxImmune is developing an immune system enhancement drug, to improve cancer patient outcomes currently on Immune Checkpoint Inhibitors, Keytruda and Opdivo.  Effecting millions of cancer patients and generating billions on revenue. Our drug has been proven in humans as a single agent and will be back in human trails as a combination therapy in 2020.

AxonDx has developed the most advanced, smallest fluorescent microscope powered by Artificial Intelligence to find and analyze cancer derived material in a patients blood.

Axon Optics is developing optical instrumentation for the telecommunications industry.

Blue Ridge Biosciences (currently no website) is commercializing new compounds to battle infectious diseases.

Caza Health is developing diagnostic equipment powered by Artificial Intelligence to more accurately diagnose women’s health issues.

At ConvergentAI™, we help you improve your business operations with predictive guidance. Improve resource productivity by focusing what matters most. Improve operational throughput by preventing future disruptions. Let us help you converge on operational excellence.